Tuberculin Testing for Persons with Positive Serologic Studies for HTLV-III
- 13 February 1986
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 314 (7) , 447
- https://doi.org/10.1056/nejm198602133140713
Abstract
To the Editor: Persons who are seropositive for HTLV-III are at high risk for the development of T-cell immunosuppression of varying degrees of severity,1 and those who are concurrently infected with Mycobacterium tuberculosis (i.e., those with positive tuberculin skin tests) may therefore also be at high risk for contracting and then transmitting tuberculosis. In the setting of a rapidly spreading AIDS epidemic, preventive therapy with isoniazid in persons seropositive for HTLV-III and with a positive tuberculin skin test could be of major public health importance. Such chemoprophylaxis is likely to be effective, since tuberculosis responds very well to standard treatment . . .Keywords
This publication has 3 references indexed in Scilit:
- The Natural History of Infection with the Lymphadenopathy-Associated Virus Human T-Lymphotropic Virus Type IIIAnnals of Internal Medicine, 1985
- Tuberculosis, Atypical Mycobacteriosis, and the Acquired Immunodeficiency Syndrome Among Haitian and Non-Haitian Patients in South FloridaAnnals of Internal Medicine, 1984
- Immunoregulation in Infection Caused by Mycobacterium tuberculosis: The Presence of Suppressor Monocytes and the Alteration of Subpopulations of T LymphocytesThe Journal of Infectious Diseases, 1979